Abstract:

Booster vaccinations have become significant in developing herd immunity due to their ability to reduce mortality rates and the severe dangers of Covid-19. Some people support the government's program and believe that booster vaccines will help prevent Covid-19 during the epidemic. Some people, however, say they do not want booster vaccinations because they believe the first and second doses are adequate and do not want to receive additional doses. The purpose of this study is to investigate the Covid-19 vaccination booster dose policy acceptance among pregnant women. This cross-sectional study was conducted in March to April 2023. Participants were 185 pregnant women selected from several subdistrict in Malang. Instruments for data collection were a demographic questionnaire, an attitude questionnaire, a social media questionnaire, a role of health workers questionnaire, and questions about Covid-19 vaccine booster dose acceptance. Logistic regression analysis was used to assess the effects of the study variables on Covid-19 vaccine booster dose acceptance. In the regression model, the three factors of attitude (b= 0.30; SE=0.07; 95% CI= 0.16 to 0.44), social media (b= 0.47; SE=0.13; 95% CI= 0.22 to 0.73), and role of health workers (b= 0.29; SE=0.15; 95% CI= 0.01 to 0.58) had significant effects on Covid-19 vaccine booster dose acceptance (p< 0.05). Acceptance of the Covid-19 booster vaccines among pregnant women can be accelerated through their positive attitude towards the vaccination program, the proper use of social media, and the involvement of healthcare workers.

References:

[1]. Laupèze, B., Del Giudice, G., Doherty, M. T, Van der Most, R., 2021, Vaccination as a Preventative Measure Contributing to Immune Fitness. npj Vaccines, 6(1). Available from: https://dx.doi.org/10.1038/s41541-021-00354-z

[2]. Zhang, S., Yang, Z., Chen, Z. L., Yue, S. J., Zhang, S., Tang, Y. P., 2022, Why Does Covid-19 Continue to Spread Despite Mass Vaccination? Front Public Heal, 10(4).

[3]. Tiyo, B. T, Schmitz, G. J. H., Ortega, M. M., da Silva, L. T., de Almeida, A., Oshiro, T. M., et al., 2021, What Happens to the Immune System After Vaccination or Recovery From COVID-19? Life, 11(11).

[4]. Nugraha, R. R, Miranda, A. V., Ahmadi, A., Lucero-Prisno, D, E., 2021, Accelerating Indonesian COVID-19 Vaccination Rollout: A Critical Task Amid the Second Wave. Trop Med Health, 49(1). Available from: https://doi.org/10.1186/s41182-021-00367-3

[5]. Al Awaidy, S. T., Khatiwada, M., Castillo, S., Al Siyabi, H., Al Siyabi, A., Al Mukhaini. S., et al., 2022, Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman: A Cross-Sectional Study. Oman Med J, 37(3).

[6]. Rela, I. Z, Ramli, Z., Firihu, M.Z., Widayati, W., Awang, A. H., Nasaruddin, N., 2022, COVID-19 Risk Management and Stakeholder Action Strategies: Conceptual Frameworks for Community Resilience in the Context of Indonesia. Int J Environ Res Public Health, 19(15).

[7]. García-Botella, A., García-Lledó, A., Gómez-Pavón, J., Del Castillo, J. G., Hernández-Sampelayo, T., Martín-Delgado, M. C., et al., 2021, Booster or Additional Vaccination Doses in Patients Vaccinated Against COVID-19. Rev Esp Quimioter, 35(2):105–14.

[8]. Jung, J., 2021, Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications. J Korean Med Sci, 36(7):1–20.

[9]. Sarma, P., Kaur, H., Kumar, H., Mahendru, D., Avti, P., Bhattacharyya, A., et al., 2020, Virological and Clinical Cure in Covid-19 Patients Treated With Hydroxychloroquine: A Systematic Review and Meta-Analysis. J Med Virol, 92(7):776–85.

[10]. Atmar, R. L., Lyke, K. E., Deming, M. E., Jackson, L. A., Branche, A. R., El Sahly, H. M, et al., 2022, Homologous and Heterologous Covid-19 Booster Vaccinations. N Engl J Med, 386(11):1046–1057.

[11]. Costa Clemens, S. A., Weckx, L., Clemens, R., Almeida Mendes, A. V., Ramos Souza, A., Silveira, M. B. V., et al., 2022, Heterologous Versus Homologous Covid-19 Booster Vaccination in previous Recipients of Two Doses of Coronavac Covid-19 Vaccine in Brazil (RHH-001): A Phase 4, Non-Inferiority, Single Blind, Randomised Study. Lancet, 399(10324):521–9.

[12]. Cerqueira-Silva, T., Shah, S. A., Robertson, C., Sanchez, M., Katikireddi, S. V., de Araujo Oliveira, V., et al., 2023, Effectiveness of mRNA Boosters After Homologous Primary Series With BNT162b2 or ChAdOx1 Against Symptomatic Infection and Severe COVID-19 in Brazil and Scotland: A Test-Negative Design Case–Control Study. PLoS Med, 20(1):1–15.

[13]. Sapkota, B., Saud, B., Shrestha, R., Al-fahad, D., Sah, R., Shrestha, S., et al., 2022, Heterologous Prime – Boost Strategies for COVID-19 Vaccines, 1–10.

[14]. Bert, F., Scaioli, G., Vola, L., Accortanzo, D., Lo Moro, G., Siliquini, R., 2022, Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies Among OECD and EU Countries. Int J Environ Res Public Health, 19(12).

[15]. Limbu, Y. B., Huhmann, B. A., 2023, Why Some People are Hesitant to Receive COVID-19 Boosters: A Systematic Review. Trop Med Infect Dis, 8(3):159.

[16]. Galanis, P., Vraka, I., Katsiroumpa, A., Siskou, O., Konstantakopoulou, O., Katsoulas, T., et al., 2022, Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece. Vaccines, 10(7):1–12.

[17]. Meng, H., Mao, J., Ye, Q., 2022, Strategies and Safety Considerations of Booster Vaccination in COVID-19. Bosn J Basic Med Sci, 22(3):366–73.

[18]. Wong, M. T. J., Dhaliwal, S. S., Balakrishnan, V., Nordin, F., Norazmi, M. N., Tye, G. J., 2023, Effectiveness of Booster Vaccinations on the Control of COVID-19 During the Spread of Omicron Variant in Malaysia. Int J Environ Res Public Health, 20(2).

[19]. Poh, X. Y., Lee, I. R., Lim, C., Teo, J., Rao, S., Chia, P. Y., et al., 2022, Evaluation of the Safety and Immunogenicity of Different Covid-19 Vaccine Combinations in Healthy Individuals: Study Protocol for a Randomized, Subject-Blinded, Controlled Phase 3 Trial [PRIBIVAC]. Trials, 23(1):1–13, https://doi.org/10.1186/s13063-022-06345-2

[20]. Atyeo, C., Shook, L. L., Nziza, N., Deriso, E. A., Muir, C., Baez, A. M., et al., 2023, COVID-19 Booster Dose Induces Robust Antibody Response in Pregnant, Lactating, and Nonpregnant Women. Am J Obstet Gynecol, 228(1):68.e1-68.e12, https://doi.org/10.1016/j.ajog.2022.07.014

[21]. Badell, M. L., Dude, C. M., Rasmussen, S. A., Jamieson, D. J., 2022, Covid-19 Vaccination in Pregnancy. BMJ, 11.

[22]. Ryalat, S., Alduraidi, H., Al-Ryalat, S. A., Alzu’bi, M., Alzyoud, M., Odeh, N., et al., 2022, Attitudes Towards COVID-19 Booster Vaccines, Vaccine Preferences, Child Immunization, and Recent Issues in Vaccination among University Students in Jordan. Vaccines, 10(8).

[23]. Verplanken, B., Orbell, S., 2022, Attitudes Habits and Behavior Change.

[24]. Cragg, L., 2016, The Development of Stimulus and Response Interference Control in Midchildhood. Dev Psychol, 52(2):242–52.

[25]. Tharwat, S., Eleraky, E. S., Adel, T., Nassar, M. K., Saleh, M., 2023, Attitudes and Concerns Regarding Booster Dose of Covid-19 Vaccine Among Egyptian Patients with Autoimmune and Rheumatic Diseases: A Cross-Sectional Survey Study. J Pharm Policy Pract, 16(1):1–12, https://doi.org/10.1186/s40545-023-00558-9

[26]. De Giorgio, A., Kuvačić, G., Maleš, D., Vecchio, I., Tornali, C., Ishac, W., et al., 2022, Willingness to Receive COVID-19 Booster Vaccine: Associations Between Green-Pass, Social Media Information, Anti-Vax Beliefs, and Emotional Balance. Vaccines, 10(3):1–18.

[27]. Shah, A., Coiado, O. C., 2023, COVID-19 Vaccine and Booster Hesitation Around the World: A Literature Review. Front Med, 9.

[28]. Elrod, J. K., Fortenberry, J. L., 2020, Advertising in Health and Medicine: Using Mass Media to Communicate With Patients. BMC Health Serv Res, 20(Suppl 1):1–8, https://dx.doi.org/10.1186/s12913-020-05599-3

[29]. Piekos, S., Hwang, Y. M., Roper, R., Sorensen, T., Price, N., Hood, L., et al., 2022, The Effect of COVID-19 Vaccination and Booster on Maternal-Fetal Outcomes. SSRN Electron J.

[30]. Osuagwu, U. L., Mashige, K. P., Ovenseri-Ogbomo, G., Envuladu, E. A., Abu, E. K., Miner, C. A., et al., 2023, The Impact of Information Sources on Covid-19 Vaccine Hesitancy and Resistance in Sub-Saharan Africa. BMC Public Health, 23(1):1–16, https://doi.org/10.1186/s12889-022-14972-2

[31]. Okorie, N., 2022, Global Media Framing, COVID-19 and the Issue of Vaccination: An Empirical Inquisition. Heal Promot Perspect, 12(2):186–191.

[32]. Wang, Y., Dai, Y., Li, H., Song, L., 2021, Social Media and Attitude Change: Information Booming Promote or Resist Persuasion? Front Psychol, 12(6):1–9.

[33]. Kreslake, J. M., Elkins, A., Thomas, C. N., Gates, S., Lehman, T., 2019, Use of Mass Communication by Public Health Programs in Nonmetropolitan Regions. Prev Chronic Dis, 16(7):1–6.

[34]. Kanchan, S., Gaidhane, A., 2023, Social Media Role and its Impact on Public Health: A Narrative Review. Cureus, 15(1):1–10.

[35]. Stellefson, M., Paige, S. R., Chaney, B. H., Chaney, J. D., 2020, Evolving Role of Social Media in Health Promotion: Updated Responsibilities for Health Education Specialists. Int J Environ Res Public Health, 17(4).

[36]. Joseph, A. M., Fernandez, V., Kritzman, S., Eaddy, I., Cook, O. M., Lambros, S., et al., 2022, COVID-19 Misinformation on Social Media: A Scoping Review. Cureus, 14(4):6–15.

[37]. Ahmad Rizal, A. R., Nordin, S. M., Ahmad, W. F. W., Ahmad Khiri, M. J., Hussin, S. H., 2022, How Does Social Media Influence People to Get Vaccinated? The Elaboration Likelihood Model of a Person’s Attitude and Intention to Get COVID-19 Vaccines. Int J Environ Res Public Health, 9(4).

[38]. Bardus, M., Assaf, S. A., Sakr, C. J., 2023, Using Social Marketing to Promote COVID-19 Vaccination Uptake: A Case Study from the “AUBe Vaccinated” Campaign. Vaccines, 11(2):1–14.

[39]. Ahiakpa, J. K., Cosmas, N. T., Anyiam, F. E., Enalume, K. O., Lawan, I., Gabriel, I. B., et al., 2022, COVID-19 Vaccines Uptake: Public knowledge, Awareness, Perception and Acceptance Among Adult Africans. PLoS One, 17(6):1–21, https://dx.doi.org/10.1371/journal.pone.0268230

[40]. Su, L., Du, J., Du, Z., 2022, Government Communication, Perceptions of COVID-19, and Vaccination Intention: A Multi-Group Comparison in China. Front Psychol, 12(1):1–11.

[41]. Elwy, A. R., Maguire, E. M., Kim, B., West, G. S., 2022, Involving Stakeholders as Communication Partners in Research Dissemination Efforts. J Gen Intern Med, 37:123–7.

[42]. Hudson, A., Montelpare, W. J., 2021, Predictors of Vaccine Hesitancy: Implications for Covid-19 Public Health Messaging. Int J Environ Res Public Health, 18(15).

[43]. Rao, R., Koehler, A., Beckett, K., Sengupta, S., 2022, COVID-19 Vaccine Mandates for Healthcare Professionals in the United States. Vaccines, 10(9):1–7.

[44]. Andrade, G., Bedewy, D., Bani, I., 2022, Motivational Factors to Receive the COVID-19 Vaccine in the United Arab Emirates: A Cross-Sectional Study. J Community Health, 47(3):530–8, https://doi.org/10.1007/s10900-022-01084-6

[45]. Soni, G. K., Bhatnagar, A., Gupta, A., Kumari, A., Arora, S., Seth, S., et al., 2023, Engaging Faith-Based Organizations for Promoting the Uptake of COVID-19 Vaccine in India: A Case Study of a Multi-Faith Society. Vaccines, 11(4).

[46]. Elmore, C. E., Blackstone, S. R., Carpenter, E. L., de Cortez, P. I., O’donnell, C., Uhlmann, E., et al., 2022, Advancing COVID-19 Vaccination Equity Among the Refugee Community: An Innovative Multi-Sector Collaborative Outreach Program. J Health Care Poor Underserved, 33(2):25–43.